Soul singer Charles Bradley has died from stomach cancer at the age of 68.
The former James Brown impersonator, nicknamed “the screaming eagle of soul” found fame in his later years. He released his first album No Time For Dreaming in 2011, aged 62.
Charles Bradley had recently returned to live performance after receiving treatment for stomach cancer late last year.
The singer’s death comes just two weeks after the remainder of his 2017 tour dates were canceled due to illness.
Charles Bradley spent much of his life working odd jobs as a handyman – and some of it living on the streets, sleeping in subway cars in New York City.
However, he continued to pursue music, having been inspired by James Brown during a performance he saw as a teenager.
Image source Wikimedia
Charles Bradley was eventually signed to a New York label in the early 2000s, securing a spot as the opening act on tour for soul revival singer Sharon Jones – who died last year aged 60.
He recorded a string of singles before the release of No Time for Dreaming a decade later. It was named one of Rolling Stone magazine’s best albums of the year.
Charles Bradley’s critical success led to live performances at some of the world’s top music festivals, including Glastonbury, Coachella, and Primavera Sound.
His rags-to-riches story was the subject of the documentary Charles Bradley: Soul of America. It followed Charles Bradley from his initial signing to the record label, living in crippling debt, to his sold-out album release show.
Earlier in September, when announcing the tour’s cancelation, a message attributed to Charles Bradley on his social media accounts said: “I love all of you out there that made my dreams come true.
“When I come back, I’ll come back strong, with God’s love. With God’s will, I’ll be back soon.”
Confirming news of Charles Bradley’s death, his publicist said: “Mr. Bradley was truly grateful for all the love he’s received from his fans and we hope his message of love is remembered and carried on.”
Dolly Parton has denied the National Enquirer report that claimed she has stomach cancer.
The gossip publication published a story saying that the 69-year-old singer had been rushed to hospital.
In a statement on her website, Dolly Parton said: “There is absolutely no truth at all that I have stomach cancer.”
“It is true that I had kidney stones,” she said.
“I had them removed three weeks ago and I am doing just fine!”
Dolly Parton added that she was already back at work following the operation.
“I am back to work and last week I was at Dollywood filming parts for my new movie Coat of Many Colors,” the singer wrote.
“I love and appreciate everyone’s concern.”
Fears for Dolly Parton’s health were sparked when Don Henley said she had overcome a “medical issue” to shoot a video with him in Los Angeles.
Speaking during an interview at the Americana Music Festival in September, The Eagles star said Dolly Parton had “got out of the hospital bed” to join him in the video for When I Stop Dreaming.
9/11 survivor Marcy Borders, who is known as “Dust Lady” after being photographed covered in dust while fleeing the World Trade Center, has died of stomach cancer at the age of 42.
Marcy Borders’ death was announced by her family on Facebook.
The woman was diagnosed with stomach cancer in 2014 at the age of 41.
The iconic 9/11 photo of Marcy Borders was taken by AFP photographer Stan Honda as the attacks on the Twin Towers unfolded.
Marcy Borders, who was 28 at the time of the attacks, was working on the 81st floor of the World Trade Center’s North Tower when the first plane hit. She fled down the stairwell and emerged from the building as the South Tower fell, covering her in dust and debris.
Photo Jersey Journal
She said a stranger pulled her to safety in a nearby building, where Stan Honda took the now-famous photo.
Marcy Borders kept the clothes she was wearing – still covered in ash – in a plastic bag in her wardrobe, but as of 2011 had never looked at them, the Telegraph reported.
In the next 10 years following 9/11 attacks, Marcy Borders grappled with depression and substance abuse. She checked into a rehab center in 2011.
In an interview with the Jersey Journal in 2014, Marcy Borders speculated that her cancer was related to the attacks.
The number of cancer cases linked to 9/11 attacks has grown in recent years.
As of May 2015, the Centers for Disease Control and Prevention (CDC) reported more than 4,000 first responders, rescue workers and survivors who have been diagnosed with cancer linked to the attacks.
The CDC said skin cancer, prostate cancer and non-Hodgkin’s lymphoma are among the most common illnesses among those individuals.
Animal tests suggested that Botox injections may help fight cancer.
The new study, published in Science Translational Medicine, showed nerves help stomach cancers grow.
Research on mice found that using the toxin beloved by those seeking a wrinkle-free face to kill nerves could halt the growth of stomach tumors and make them more vulnerable to chemotherapy.
Botox is usually used in the fight against the signs of ageing, not cancer.
The toxin disrupts nerve function to relax muscles and even out wrinkles, but a growing body of work suggests nerves can also help fuel cancer growth.
Scientists Columbia University Medical Centre, in New York, and the Norwegian University of Science and Technology in Trondheim investigated the role of the vagus nerve – which runs from the brain to the digestive system – in stomach cancer.
Research on mice found that using Botox to kill nerves could halt the growth of stomach tumors and make them more vulnerable to chemotherapy
Either cutting the nerve or using the toxin Botox slowed the growth of tumors or made them more responsive to chemotherapy.
Dr. Timothy Wang, one of the scientists in the study, said: “If you just cut nerves is it going to cure cancer? Probably not.
“At least in early phase, if you [disrupt the nerve] the tumor becomes much more responsive to chemotherapy, so we don’t see this as a single cure, but making current and future treatments more effective.”
Some trials have started in people who are having surgery to remove a stomach cancer. There has also been research suggesting nerves may have a role in prostate cancer too.
However, Dr. Timothy Wang acknowledged that there was a long way to go before this could be considered a treatment.
“With everything new in cancer, even if it looks great, when you start to roll it out to patients it always seems cancer is smarter than we are.
“Tumors have the ability to out-evolve any single agent, knocking one leg of a stool is probably not going to topple it.
“But I think this has a lot of potential and in a decade or two I can see these pathways being targeted.”
Taking aspirin every day can reduce the chance of developing or dying from bowel and stomach cancers, a Queen Mary University of London research team reports in the Annals of Oncology.
Scientists examined some 200 studies investigating the benefits and harms of taking aspirin – an area of continuing medical debate.
They found the drug reduced the number of cases and deaths from bowel, stomach and esophageal cancer by some 30-40%.
There was weaker and more variable evidence that the drug reduced deaths from breast, prostate and lung cancer too.
And the study found people needed to take the drug for at least five years to see any benefits.
Prof. Jack Cuzick, at Queen Mary University of London, who led the research, urged all healthy people aged 50 and above to consider taking a small dose (75mg) of the drug every day for a decade.
Taking aspirin every day can reduce the chance of developing or dying from bowel and stomach cancers
Researchers predicted if 1,000 individuals aged 60 took the drug for 10 years, a further decade later there would be:
16 fewer deaths from cancer
One fewer death from heart attack
Two extra deaths from bleeding
Prof. Jack Cuzick, who has been taking aspirin for four years, said: “Whilst there are some serious side-effects that can’t be ignored, taking aspirin daily looks to be the most important thing we can do to reduce cancer after stopping smoking and reducing obesity, and will probably be much easier to implement.”
They found benefits continued even when people stopped taking the drug, but say it is unclear exactly how long people should use it for.
As the risk of internal bleeding rises as an individual gets older, they suggest a cut-off point of 10 years.
There is still uncertainty whether other doses of the drug could offer more protection.
Aspirin’s well known possible side-effects include bleeding in the stomach and the brain.
Experts warn anyone at high risk of bleeding, including people with blood disorders who take blood thinning medication, or are frequent smokers or drinkers, are more likely to suffer these side-effects.
They recommend anyone considering daily medication should speak to their doctors to discuss individual risks.
Exactly how aspirin protects against cancer is unknown. Scientists suggest it may reduce inflammation or act on blood cells that would otherwise encourage the spread of the disease.
A new study findings reveal that a quick and simple breath test can diagnose stomach cancer.
Scientists from Israel and China found the test was 90% accurate at detecting and distinguishing cancers from other stomach complaints in 130 patients.
The British Journal of Cancer says the test could revolutionize and speed up the way this cancer is diagnosed.
Two-fifths of patients survive for at least a year, but only a fifth are still alive after five years, despite treatment.
Currently doctors diagnose stomach cancer by taking a biopsy of the stomach lining using a probe and a flexible camera passed via mouth and down the gullet.
The new test looks for chemical profiles in exhaled breath that are unique to patients with stomach cancer.
A quick and simple breath test can diagnose stomach cancer
Cancer appears to give off a signature smell of volatile organic compounds that can be detected using the right technical medical kit – and perhaps even dogs.
The science behind the test itself is not new – many researchers have been working on the possibility of breath tests for a number of cancers, including lung.
But the work by Prof. Hossam Haick, of the Technion-Israel Institute of Technology, suggests it is a good way to spot stomach cancer.
In the study, 37 of the patients had stomach cancer, 32 had stomach ulcers and 61 had other stomach complaints.
As well as accurately distinguishing between these conditions 90% of the time, the breath test could tell the difference between early and late-stage stomach cancers.
The team are now running a bigger study in more patients to validate their test.
World Cancer Research Fund (WCRF) has advised that cutting back on salty foods such as bacon, bread and breakfast cereals may reduce people’s risk of developing stomach cancer.
It wants people to eat less salt and for the content of food to be labelled more clearly.
Too much salt is bad for blood pressure and can lead to heart disease and stroke, but it can also cause cancer.
The recommended daily limit is 6 g, about a level teaspoonful, but the World Cancer Research Fund said people were eating 8.6 g a day.
WCRF estimated that 14% of cases, around 800, could be avoided if everyone stuck to their 6 g a day.
Too much salt is bad for blood pressure and can lead to heart disease and stroke, but it can also cause cancer
Kate Mendoza, head of health information at WCRF, said: “Stomach cancer is difficult to treat successfully because most cases are not caught until the disease is well-established.
“This places even greater emphasis on making lifestyle choices to prevent the disease occurring in the first place – such as cutting down on salt intake and eating more fruit and vegetables.”
Eating too much salt is not all about sprinkling it over fish and chips or Sunday lunch, the vast majority is already inside food.
It is why the WCRF has called for a “traffic-light” system for food labelling – red for high, amber for medium and green for low.
However, this has proved controversial with many food manufacturers and supermarkets preferring other ways of labelling food.
This website has updated its privacy policy in compliance with EU GDPR 2016/679. Please read this to review the updates about which personal data we collect on our site. By continuing to use this site, you are agreeing to our updated policy. AcceptRejectRead More
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
